Look through the key statistics analysis before diving in deeper into our report:
Parameter | Current result | Assessment |
---|---|---|
Meta title | Tarceva® (erlotinib) for mNSCLC & Advanced-Stage Pancreatic Cancer | As meta title is a ranking factor, it's quite important to stick to search engine recommended length of aroun 50-60 characters. This website's meta title is 66 characters long. |
Description | Learn about Tarceva®, indicated for 1st line, maintenance, or 2nd or greater-line EGFRm+ Del19 or L858R mNSCLC and advanced-stage pancreatic cancer treatment. Who is Tarceva (erlotinib) for? Tarceva is prescribed for patients with non-small cell lung cancer (NSCLC) whose cancer has spread to other parts of the body and that has certain types of epidermal growth factor receptor (EGFR) mutations. Your healthcare provider will perform a test to make sure that Tarceva is right for you. It is not known if Tarceva is safe and effective in EGFR mutations other than those included in the FDA-approved prescribing information. Tarceva is not meant to be used at the same time as certain types of chemotherapy for NSCLC. Tarceva is approved for advanced-stage pancreatic cancer. Tarceva in combination with gemcitabine is prescribed for patients with advanced-stage pancreatic cancer whose cancer has spread, grown, or cannot be surgically removed and who have not received previous chemotherapy. Important Safety Information: Contact your HCP right away if you experience any of the side effects listed below. What are the possible side effects of Tarceva? Tarceva can cause serious side effects, including: Lung problems (called interstitial lung disease [ILD] events). Tarceva has been shown to cause lung problems, including death. Symptoms of lung problems may include shortness of breath, cough, and fever. Tarceva may need to be stopped if you have any of these symptoms. Liver and kidney problems. Tarceva has been shown to cause severe kidney and liver problems, including death. Some people had their kidneys and liver stop working. Let your HCP know if you have a history of liver or kidney disease. Stomach and intestinal problems (called gastrointestinal [GI] perforation). Tarceva has been shown to cause GI perforation, which has led to death. A GI perforation is a hole that develops in your stomach or intestine. Tarceva patients may be at a higher risk for GI perforation if they: Are taking medicines including those that may help block the growth of blood vessels; steroids; non-steroidal anti-inflammatory drugs (NSAIDs); and certain chemotherapies. Always tell your HCP about any medicines you are taking. Have a history of ulcers or other stomach disease. Serious skin conditions. Tarceva has been shown to cause blistering and skin peeling. This may result in other serious skin disorders or death. Blood, bleeding, and clotting problems. Tarceva has been shown to cause certain blood problems and other bleeding and clotting problems. These have led to stroke and death. Eye disorders. Tarceva has been shown to cause dry eyes, unusual eyelash growth, or swelling of the cornea. The cornea is the clear coating of the eyeball. This swelling may irritate or damage the eye. Bleeding events when taking warfarin with Tarceva. Tell your HCP if you are taking a blood thinner, such as warfarin. Taking Tarceva with this medicine can cause death. Pregnancy. Tarceva can harm an unborn baby. Women should use effective birth control during treatment and for at least 1 month after the last dose of Tarceva. Tell your HCP if you have become pregnant, or if you think you may be pregnant, during treatment with Tarceva. Do not breast-feed during treatment with Tarceva and for 2 weeks after the final dose. When should I call my HCP while taking Tarceva? Call your HCP if you have: Serious or ongoing diarrhea, nausea (feeling sick to your stomach), loss of appetite, or vomiting. New or worsening shortness of breath or cough. Eye irritation. New or worsening rash, blistering, or peeling of the skin. Any changes in smoking habits. What are some of the most common side effects of Tarceva? In 1st-line NSCLC treatment: Diarrhea, weakness, rash, cough, shortness of breath, loss of appetite (not wanting to eat). In maintenance/2nd- or 3rd-line NSCLC treatment: Rash and diarrhea. In pancreatic cancer treatment: Fatigue (feeling very tired), rash, nausea, loss of appetite, diarrhea. What should I know about skin (including rash), hair, and nail problems or diarrhea while taking Tarceva? Skin (including rash): While taking Tarceva, rash could happen or get worse if the skin is exposed to the sun. You may want to use alcohol-free lotions and sunscreens or avoid being out in the sun. Your skin and nails may get darker. You may also have dry skin that may or may not crack. This most often happens with rash. Talk with your HCP if you notice a rash. He or she may be able to help you manage it. Hair and nails: Hair and nail problems have been seen in patients taking Tarceva. These include increased hairiness and brittle or loose nails. Diarrhea: Diarrhea can usually be treated with anti-diarrhea medicine. Your HCP can help you find the right medicine for you. What should I do if I am taking or am prescribed other medicines or supplements while taking Tarceva? Always tell your HCP about all of the medicines and herbal supplements you are taking. DO NOT start taking any new medicines or herbal supplements before talking with your HCP. DO NOT eat grapefruit or drink grapefruit juice before talking with your HCP. Will smoking affect my treatment with Tarceva? If you smoke, you should stop smoking before you start treatment with Tarceva. If you continue to smoke, your treatment with Tarceva may need to be adjusted. Talk with your HCP if you continue to smoke. Always talk with your HCP about any side effects you may have with Tarceva. You may report side effects to the FDA at (800) FDA-1088 or www.fda.gov/medwatch. You may also report side effects to Genentech at (888) 835-2555. Please see Tarceva full Product Information for additional Important Safety Information. | This meta description is 5778 characters in length. Google suggests up to 320 characters at the very most to make sure the whole meta description is visible in search results page. |
Site speed | Around 5.5796 seconds | Website ranking and usability can be greatly improved by reducing the time it takes to load it. |
Alexa global rank | 2312193, as last checked | Based on Alexa Global, we can assume the website is not very popular. Mind you, Alexa's worth is questionable at best. |
Quantcast | Current rank, according to our database, is at 28179 | The website seems to enjoy good popularity, according to Quantcast. |
Links on homepage | Around 98 links | This is a well-judged amount of links for a homepage. |
Backlinks amount | Approximately 64 | The number of backlinks seems awfully low. If possible, the webmaster should work towards building more through quality content and public awareness. |
HTML size | 58.7KB | Ah. Well. We were hoping for better results... We would urge the website owners to improve load speed as soon as possible. |
Website host server overview | Server status: online. Server IP address for this website is 72.34.128.212. | We apologize, but for some reason we were unable to gather enough data to provide a detailed insight at this time. |
If the basic information we presented you with above is not enough, get ready to dive in much deeper!
Now that the numbers are taken care of, we can go deeper and try to analyse the website from a user's perspective. More specifically, let's see if we can identify the target audience as well as a few related websites and categories.
Parameter | Current result | Assessment |
---|---|---|
Related categories | Health Pharmacy Drugs and Medications E Erlotinib |
The website falls into one or all of these categories, and, obviously, these are the areas of interest for the target audience. |
Alternative websites | egfr-mutation.com erivedge.com thrivingwithlungcancer.com trovagene.com ingearcoaching.com |
These websites fall into the same categories as tarceva.com, more or less. By extension, they compete with the analysed website for the same target audience. |
Website safety – both in terms of malicious actions as well as of the content itself – is a key factor that should not be underestimated. With not only viruses, but also harmful and hateful articles and opinions aplenty, it's important to protect our computers and friends and family from any harm.
Trying to acquire very accurate visitor data is immensely difficult and can only be done when given direct access to the server. However, there are ways to get approximate numbers.
The numbers themselves probably say enough, but we'll add some insight where possible.
Parameter | Current result | Assessment |
---|---|---|
Approximate time on site | 3:30 | Wow, that's a great average result! The website must have some incredible content to keep visitors occupied. |
ALEXA rating is based on the number of visitors a given page receives. The higher the visitor count, the higher the rating. Currently, ALEXA has over 4 million websites indexed. If you sense cynicism in our words, you're not mistaken - we think Alexa rating is overrated, to put it mildly. A website's worth (and contextual popularity) is more than the sum of the views. So take the rank with a grain of salt.
QUANTCAST is a data processing company that mostly gathers information for advertising companies. It specializes in real-time audience analysis and, as you may have gathered, is really quite similar to Alexa, if perhaps not as infamous. To our knowledge, the company has rated and ranked approximately 36906640 websites so far. There is always a caveat with these sort of ranking systems - they don't really take any context into account. As such, their usefulness is debatable at best. Don't overthink this rank - it's just a number, really.
Servers are physical storage devices that contain all the files and databases associated with a specific website, sometimes more than one. At times, a server makes up several virtual devices - separate servers used for shared hosting (tends to be cheaper). Entering website address into the address bar of your browser starts the request process during which your browser contacts the server and asks for specific files and database entries in order to display the requested website.
What follows is certainly very geeky, but informative for the knowing. Dig in:
Header detail |
---|
HTTP/1.1 200 OK Expires: Sun, 19 Nov 1978 05:00:00 GMT Last-Modified: Sat, 20 May 2017 23:33:32 GMT Cache-Control: no-cache, must-revalidate, post-check=0, pre-check=0 ETag: "1495323212" Content-Language: en Link: <//www.tarceva.com/patient/node/47>; rel="shortlink" Content-Type: text/html; charset=utf-8 Content-Length: 59540 Accept-Ranges: bytes Date: Sat, 20 May 2017 23:33:32 GMT X-Varnish: 1152222827 Age: 0 Connection: close X-Cache: MISS Set-Cookie: BIGipServerws_drupalprd_pool=!QSLYRw9Vj5X/s3/hZrY1cYfRyoiyA6YoVnqpPElp5rOUvTgSO2ZE1T2GqYLElpzl5E40noSyig6wWlM=; path=/ |
WHOIS |
---|
Whois Server Version 2.0 Domain names in the .com and .net domains can now be registered with many different competing registrars. Go to http://www.internic.net for detailed information. Domain Name: TARCEVA.COM Registrar: GODADDY.COM, LLC Sponsoring Registrar IANA ID: 146 Whois Server: whois.godaddy.com Referral URL: http://www.godaddy.com Name Server: DNADNS1E.GENE.COM Name Server: DNADNS2E.GENE.COM Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Updated Date: 01-may-2015 Creation Date: 04-may-2001 Expiration Date: 04-may-2018 >>> Last update of whois database: Fri, 19 May 2017 00:39:30 GMT <<< For more information on Whois status codes, please visit https://icann.org/epp NOTICE: The expiration date displayed in this record is the date the registrar's sponsorship of the domain name registration in the registry is currently set to expire. This date does not necessarily reflect the expiration date of the domain name registrant's agreement with the sponsoring registrar. Users may consult the sponsoring registrar's Whois database to view the registrar's reported date of expiration for this registration. TERMS OF USE: You are not authorized to access or query our Whois database through the use of electronic processes that are high-volume and automated except as reasonably necessary to register domain names or modify existing registrations; the Data in VeriSign Global Registry Services' ("VeriSign") Whois database is provided by VeriSign for information purposes only, and to assist persons in obtaining information about or related to a domain name registration record. VeriSign does not guarantee its accuracy. By submitting a Whois query, you agree to abide by the following terms of use: You agree that you may use this Data only for lawful purposes and that under no circumstances will you use this Data to: (1) allow, enable, or otherwise support the transmission of mass unsolicited, commercial advertising or solicitations via e-mail, telephone, or facsimile; or (2) enable high volume, automated, electronic processes that apply to VeriSign (or its computer systems). The compilation, repackaging, dissemination or other use of this Data is expressly prohibited without the prior written consent of VeriSign. You agree not to use electronic processes that are automated and high-volume to access or query the Whois database except as reasonably necessary to register domain names or modify existing registrations. VeriSign reserves the right to restrict your access to the Whois database in its sole discretion to ensure operational stability. VeriSign may restrict or terminate your access to the Whois database for failure to abide by these terms of use. VeriSign reserves the right to modify these terms at any time. The Registry database contains ONLY .COM, .NET, .EDU domains and Registrars. Domain Name: TARCEVA.COM Registrar URL: http://www.godaddy.com Registrant Name: Thomas Bauer Registrant Organization: Astellas US LLC Name Server: DNADNS1E.GENE.COM Name Server: DNADNS2E.GENE.COM DNSSEC: unsigned For complete domain details go to: http://who.godaddy.com/whoischeck.aspx?domain=TARCEVA.COM The data contained in GoDaddy.com, LLC's WhoIs database, while believed by the company to be reliable, is provided "as is" with no guarantee or warranties regarding its accuracy. This information is provided for the sole purpose of assisting you in obtaining information about domain name registration records. Any use of this data for any other purpose is expressly forbidden without the prior written permission of GoDaddy.com, LLC. By submitting an inquiry, you agree to these terms of usage and limitations of warranty. In particular, you agree not to use this data to allow, enable, or otherwise make possible, dissemination or collection of this data, in part or in its entirety, for any purpose, such as the transmission of unsolicited advertising and and solicitations of any kind, including spam. You further agree not to use this data to enable high volume, automated or robotic electronic processes designed to collect or compile this data for any purpose, including mining this data for your own personal or commercial purposes. Please note: the registrant of the domain name is specified in the "registrant" section. In most cases, GoDaddy.com, LLC is not the registrant of domain names listed in this database. |
Now that you are hopefully done with tarceva.com, we invite you to read more of our in-depth reports. Try entering a new domain address in the search form at the top of this page, or on the homepage. Alternatively, refer to this list for more website overviews:
We have found so many alternative TLD extensions for tarceva.com. Here is the full list with 580 entries:
The following list of most frequent domain address mistypes associated with tarceva.com contains at least 1128 entries: